Glycerol kinase deficiency alters expression of genes involved in lipid metabolism, carbohydrate metabolism, and insulin signaling

European Journal of Human Genetics

Volumn 15, Issue 6, 2007, Pages 646-657

  Rahib, Lola ^a   MacLennan, Nicole K ^b   Horvath, Steve ^c   Liao, James C ^a   Dipple, Katrina M ^a,b,c  

^a University of California   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCEROL KINASE; INSULIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STAT3 PROTEIN; STAT5 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROWN ADIPOSE TISSUE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DNA MICROARRAY; ENZYME DEFICIENCY; GENE EXPRESSION; GENETIC DISORDER; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPID METABOLISM; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; WILD TYPE;

ADIPOSE TISSUE, BROWN; ANIMALS; CARBOHYDRATE METABOLISM; GENE EXPRESSION PROFILING; GLYCEROL KINASE; INSULIN; LIPID METABOLISM; MALE; MICE; MICE, KNOCKOUT; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

MUS;

EID: 34249662304     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201801     Document Type: Article

References (56)

1. McCabe ER: Disorders of glycerol metabolism; In: Scriver CR B, AL, Sly, WS, Valle, D, Childs, B, Vogelstein, B (eds): The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 2001, pp 2217-2237.
2. Dipple KM, McCabe ER: Phenotypes of patients with 'simple' Mendelian disorders are complex traits: Thresholds, modifiers, and systems dynamics. Am J Hum Genet 2000; 66: 1729-1735.
3. Dipple KM, Zhang YH, Huang BL et al: Glycerol kinase deficiency: evidence for complexity in a single gene disorder. Hum Genet 2001; 109: 55-62.
4. Sriram G, Martinez JA, McCabe ER, Liao JC, Dipple KM: Single-gene disorders: What role could moonlighting enzymes play? Am J Hum Genet 2005; 76: 911-924.
5. Dipple KM, Phelan JK, McCabe ER: Consequences of complexity within biological networks: Robustness and health, or vulnerability and disease. Mol Genet Metab 2001; 74: 45-50.
6. Gaudet D, Arsenault S, Perusse L et al: Glycerol as a correlate of impaired glucose tolerance: Dissection of a complex system by use of a simple genetic trait. Am J Hum Genet 2000; 66: 1558-1568.
7. Stepanian SV, Huyn ST, McCabe ER, Dipple KM: Characterization of the human glycerol kinase promoter: Identification of a functional HNF-4alpha binding site and evidence for transcriptional activation. Mol Genet Metab 2003; 80: 412-418.
8. Yamagata K FH, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS et al Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996; 384 458-460.
9. Rhee J, Inoue Y, Yoon JC et al: Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): Requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci USA 2003; 100: 4012-4017.
10. Bartoov-Shifman R, Hertz R, Wang H, Wollheim CB, Bar-Tana J, Walker MD: Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4 alpha. J Biol Chem 2002; 277: 25914-25919.
11. Wang H, Maechler P, Antinozzi PA, Hagenfeldt KA, Wollheim CB: Hepatocyte nuclear factor 4alpha regulates the expression of pancreatic beta -cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J Biol Chem 2000; 275: 35953-35959.
12. Damcott CM, Hoppman N, Ott SH et al: Polymorphisms in both promoters of hepatocyte nuclear factor 4-{alpha} are associated with type 2 diabetes in the Amish. Diabetes 2004; 53: 3337-3341.
13. Ek J, Rose CS, Jensen DP et al: The functional Thr130Ile and Val255Met polymorphisms of the hepatocyte nuclear factor-4{alpha} (HNF4A): Gene associations with type 2 diabetes or altered {beta}-cell function among Danes. J Clin Endocrinol Metab 2005; 90: 3054-3059.
14. Hansen SK, Rose CS, Glumer C et al: Variation near the hepatocyte nuclear factor (HNF)-4alpha gene associates with type 2 diabetes in the Danish population. Diabetologia 2005; 48: 452-458.
15. Bagwell AM, Bento JL, Mychaleckyj JC, Freedman BI, Langefeld CD, Bowden DW: Genetic analysis of HNF4A polymorphisms in Caucasian-American type 2 diabetes. Diabetes 2005; 54: 1185-1190.
16. Mohlke KL, Boehnke M: The role of HNF4A variants in the risk of type 2 diabetes. Curr Diab Rep 2005; 5: 149-156.
17. Silander K, Mohlke KL, Scott LJ et al: Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes 2004; 53: 1141-1149.
18. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995; 270: 12953-12956.
19. Guan HP, Li Y, Jensen MV, Newgard CB, Steppan CM, Lazar MA: A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med 2002; 8: 1122-1128.
20. Guan HP, Ishizuka T, Chui PC, Lehrke M, Lazar MA: Corepressors selectively control the transcriptional activity of PPAR{gamma} in adipocytes. Genes Dev 2005; 19: 453-461.
21. Ashcroft F, Rorsman N: Type 2 diabetes mellitus: not quite exciting enough? Hum Mol Genet 2004; 13 (Spec no.): 1R21-1R31.
22. Salway J: Metabolism at a Glance. Nashville: Blackwell publisher, 2004.
23. Chakrabarty K, Chaudhuri B, Jeffay H: Glycerokinase activity in human brown adipose tissue. J Lipid Res 1983; 24: 381-390.
24. Valverde AM, BenitA M: The brown adipose cell: a unique model for understanding the molecular mechanism of insulin resistance. Mini Rev Med Chem 2005; 5: 269-278.
25. Valverde AM, BenitA M, Lorenzo M: The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance. Acta Physiol Scand 2005; 183: 59-73.
26. Sell H, DeshaieU Y, Richard D: The brown adipocyte: update on its metabolic role. Int J Biochem Cell Biol 2004; 36: 2098.
27. Festuccia WTL, Kawashita NH, Garofalo MAR et al: Control of glyceroneogenic activity in rat brown adipose tissue. Am J Physiol Regul Integr Comp Physiol 2003; 285: R177-182.
28. Liao JC, Boscolo R, Yang YL, Tran LM, Sabatti C, Roychowdhury VP: Network component analysis: Reconstruction of regulatory signals in biological systems. Proc Natl Acad Sci USA 2003; 100: 15522-15527.
29. Kao KC, Yang YL, Boscolo R, Sabatti C, Roychowdhury V, Liao JC: Transcriptome-based determination of multiple transcription regulator activities in Escherichia coli by using network component analysis. Proc Natl Acad Sci USA 2004; 101: 641-646.
30. Huq AH, Lovell RS, Ou CN, Beaudet AL, Craigen WJ: X-linked glycerol kinase deficiency in the mouse leads to growth retardation, altered fat metabolism, autonomous glucocorticoid secretion and neonatal death. Hum Mol Genet 1997; 6: 1803-1809.
31. MacLennan NK, Rahib L, Shin C et al: Targeted disruption of glycerol kinase gene in mice: Expression analysis in liver shows alterations in network partners related to glycerol kinase activity. Hum Mol Genet 2006; 15: 405-415.
32. Li CW: WH: DNA-Chip Analyzer (dChip); In: Parmigiani G GE, Irizarry R, Zeger, SL (eds): The analysis of gene expression analysis and software. Springer: New York, 2003, pp 120-141.
33. Hosack D, Dennis G, Sherman B, Lane H, Lempicki R: Identifying biological themes within lists of genes with EASE. Genome Biology 2003; 4: R70.
34. Livak KJ, Schmittgen TD: Analysis of relative gene expression data sing real-time quantitative PCR and the 2-[Delta][Delta]CT method. Methods 2001; 25: 402-408.
35. Kuwada N, Nagano K, MacLennan N et al: Gene therapy for murine glycerol kinase deficiency: Importance of murine ortholog. Biochem Biophys Rese Commun 2005; 335: 247.
36. Angel P, Allegretto EA, Okino ST et al: Oncogene jun encodes a sequence-specific trans- activator similar to AP-1. Nature 1988; 332: 166.
37. Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell 2000; 103: 239.
38. Angel P, Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim et Biophys Acta (BBA) - Rev Cancer 1991; 1072: 129.
39. Ip YT, Davis RJ: Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr Opin Cell Biol 1998; 10: 205.
40. Martinez Agosto JA, McCabe ERB: Conserved family of glycerol kinase loci in Drosophila melanogaster. Mol Genet Metab 2006; 88: 334.
41. McCabe ER: Microcompartmentation of energy metabolism at the outer mitochondrial membrane: Role in diabetes mellitus and other diseases. J Bioenerg Biomembr 1994; 26: 317-325.
42. Seltzer WK, McCabe ER: Subcellular distribution and kinetic properties of soluble and particulate-associated bovine adrenal glycerol kinase. Mol Cell Biochem 1984; 64: 51-61.
43. Cesura AM, Pinard E, Schubenel R et al: The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore. J Biol Chem 2003; 278: 49812-49818.
44. Ortmeyer HK: In vivo insulin regulation of skeletal muscle glycogen synthase in calorie-restricted and in ad libitum-fed rhesus monkeys. J Nutr 2001; 131: 907S-9912.
45. Villar-Palasi C, Guinovart J: The role of glucose 6-phosphate in the control of glycogen synthase. FASEB J 1997; 11: 544-558.
46. Abe H, Bandai A, Makuuchi M et al: Hyperinsulinaemia accelerates accumulation of cholesterol ester in aorta of rats with transplanted pancreas. Diabetologia 1996; 39: 1276-1283.
47. Huang KP: The mechanism of protein kinase C activation. Trends Neurosci 1989; 12: 425-432.
48. Griffin M, Marcucci M, Cline G et al: Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999; 48: 1270-1274.
49. Schmitz-Peiffer C, Browne C, Oakes N et al: Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 1997; 46: 169-178.
50. Chen J-S, Exton JH: Regulation of phospholipase D2 activity by protein kinase C{alpha}. J Biol Chem 2004; 279: 22076-22083.
51. Olorunseun OO, Ian LPB: The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt. Int J Colorectal Dis 2007; 22: 401-409.
52. Samson S, Wong N: Role of Sp1 in insulin regulation of gene expression. J Mol Endocrinol 2002; 29: 265-279.
53. Koster A, Chao YB, Mosior M et al: Transgenic angiopoietin-like (Angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 2005; 146 4943-4950.
54. Cases S, Stone SJ, Zhou P et al: Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem 2001; 276: 38870-38876.
55. Maeda N, Funahashi T, Hibuse T et al: Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue. Proc Natl Acad Sci USA 2004; 101: 17801-17806.
56. Hibuse T, Aaeda N, Funahashi T et al: From the cover: aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc Natl Acad Sci USA 2005; 102 10993-10998.